<!DOCTYPE html>
<html lang="en">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8">

		<!-- Адаптирование страницы для мобильных устройств -->
		<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">

		<!-- Запрет распознования номера телефона -->
		<meta name="format-detection" content="telephone=no">
		<meta name="SKYPE_TOOLBAR" content ="SKYPE_TOOLBAR_PARSER_COMPATIBLE">

		<!-- Заголовок страницы -->
		<title>Заголовок страницы</title>

		<!-- Данное значение часто используют(использовали) поисковые системы -->
		<meta name="description" content="">
		<meta name="keywords" content="">

		<!-- Традиционная иконка сайта, размер 16x16, прозрачность поддерживается. Рекомендуемый формат: .ico или .png -->
		<link rel="shortcut icon" href="favicon.ico">

		<!-- Изменение цвета панели моб. браузера -->
		<meta name="msapplication-TileColor" content="#006fb1">
		<meta name="theme-color" content="#006fb1">

		<!-- Подключение шрифтов с гугла -->
		<link rel="preconnect" href="https://fonts.gstatic.com">
		<link href="https://fonts.googleapis.com/css2?family=Raleway:ital,wght@0,300;0,400;0,500;0,600;0,700;0,800;0,900;1,300;1,400;1,500;1,600;1,700;1,800;1,900&display=swap" rel="stylesheet">

		<!-- Подключение файлов стилей -->
		<link rel="stylesheet" href="css/owl.carousel.css">
		<link rel="stylesheet" href="css/fancybox.css">
		<link rel="stylesheet" href="css/styles.css">

		<link rel="stylesheet" href="css/response_1279.css" media="print, (max-width: 1279px)">
		<link rel="stylesheet" href="css/response_1023.css" media="print, (max-width: 1023px)">
		<link rel="stylesheet" href="css/response_767.css" media="print, (max-width: 767px)">
		<link rel="stylesheet" href="css/response_479.css" media="(max-width: 479px)">
		<link href="https://unpkg.com/aos@2.3.1/dist/aos.css" rel="stylesheet">
	</head>

	<body>
		<div class="wrap">
			<div class="main">
				<header class="absolute">
					<div class="cont row">
						<a href="/" class="logo">
							<img src="images/logo.png" alt="">
						</a>

						<nav class="menu">
							<div class="item">
								<a href="/">Patients</a>
							</div>

							<div class="item">
								<a href="/">Healthcare providers</a>
							</div>

							<div class="item">
								<a href="#" class="sub_link">Science</a>

								<div class="sub_menu">
									<div><a href="/">Technology</a></div>
									<div><a href="/">Indications</a></div>
									<div><a href="/">Clinical Trials</a></div>
									<div><a href="/">Collaborations</a></div>
									<div><a href="/">Scientific Advisory</a></div>
									<div><a href="/">Board</a></div>
								</div>
							</div>

							<div class="item">
								<a href="/">Pipeline</a>
							</div>

							<div class="item">
								<a href="/">Careers</a>
							</div>

							<div class="item">
								<a href="/">About Retrotope</a>
							</div>
						</nav>

						<div class="socials">
							<a href="/" target="_blank" rel="noopener nofollow" class="facebook">
								<svg class="icon"><use xlink:href="images/sprite.svg#ic_facebook"></use></svg>
							</a>

							<a href="/" target="_blank" rel="noopener nofollow" class="linkedin">
								<svg class="icon"><use xlink:href="images/sprite.svg#ic_linkedin"></use></svg>
							</a>

							<a href="/" target="_blank" rel="noopener nofollow" class="twitter">
								<svg class="icon"><use xlink:href="images/sprite.svg#ic_twitter"></use></svg>
							</a>

							<a href="/" target="_blank" rel="noopener nofollow" class="wikipedia">
								<svg class="icon"><use xlink:href="images/sprite.svg#ic_wikipedia"></use></svg>
							</a>
						</div>

						<div class="modal_cont search">
							<button class="btn mini_modal_btn" data-modal-id="#search_modal">
								<svg class="icon"><use xlink:href="images/sprite.svg#ic_search"></use></svg>
							</button>

							<div class="mini_modal" id="search_modal">
								<form action="">
									<input type="text" name="" value="" class="input" placeholder="Search...">

									<button type="submit" class="submit_btn">
										<svg class="icon"><use xlink:href="images/sprite.svg#ic_search"></use></svg>
									</button>
								</form>
							</div>
						</div>

						<button class="mob_menu_btn">
							<span></span>
						</button>
					</div>
				</header>


				<section class="page_head no_margin">
					<div class="cont">
						<div class="breadcrumbs">
							<a href="/">Home</a> <span class="sep"></span>
							<span class="current">Science</span>
						</div>

						<div class="page_title typeEffect1">SCIENCE AND TECHNOLOGY</div>

						<div class="page_desc text_block">
							<p>The oxidative damage to membranes is detrimental and cannot be sufficiently controlled by antioxidants. The most susceptible membrane damage that puts cells at risk of death is in the mitochondrial membrane.</p>

							<p>Retrotope’s drug platform, isotopically stabilized PUFAs, are unique in drug discovery. They are based on essential nutrient fats which have no pharmacological effect in the natural form. But, in the deuterated form, are sensitive and specific drugs with highly non-linear reduction of lipid peroxidation damage. Our compounds are expected to be active across various indications without any significant side effects.</p>
						</div>
					</div>

					<div class="parallax scene fill" id="parallax1">
						<img data-src="images/first_section_parallax_img.png" alt="" class="img lozad layer layer1 expand-width" data-depth="0.5">

						<img data-src="images/first_section_parallax_img2.png" alt="" class="img lozad layer layer2 expand-width" data-depth="0.3">
					</div>

					<div class="bg lozad" data-background-image="images/bg_page_head.jpg"></div>
				</section>


				<section class="learn_more block">
					<div class="cont row">
						<div class="icon">
							<img data-src="images/ic_learn_more.png" alt="" class="lozad">
						</div>

						<div class="info">
							<a href="/" class="details">Learn more</a>

							<div class="title">about DRUG PLATFORM RACIONALE</div>

							<div class="desc text_block">
								<p>Shchepinov filed a patent application for his potential anti-ageing invention and in 2006, together with biotech entrepreneurs Robert Molinari and Charles Cantor, he founded California-based pharma start-up Retrotope. The first thing the new company had to do was to prove the principle that isotopic substitution can extend longevity. To get some initial evidence, Shchepinov worked with collaborators to grow the roundworms Caenorhabditis elegans on isotopically enriched food to see if this increased their lifespan.</p>
							</div>
						</div>
					</div>
				</section>


				<section class="indications block">
					<div class="cont">
						<div class="block_head center">
							<div class="title">TARGET INDICATIONS</div>
						</div>


						<div class="row">
							<div class="item">
								<div class="main">Progress Phase I</div>

								<div class="sub">
									<div>INAD</div>
									<div>Freiderech's Ataxia</div>
									<div>Tay Sach Desease</div>
									<div>AMD</div>
								</div>
							</div>

							<div class="item">
								<div class="main">Progress Phase II</div>

								<div class="sub">
									<div>PSP</div>
									<div>ApoE4/E4 Alzheimer’s</div>
								</div>
							</div>

							<div class="item">
								<div class="main">Progress Phase III</div>

								<div class="sub">
									<div>ALS</div>
									<div>Huntington’s disease</div>
									<div>LHON; Geographic Atrophy</div>
								</div>
							</div>
						</div>
					</div>
				</section>


				<section class="developing block">
					<div class="cont row">
						<div class="title" data-aos="fade-right" data-aos-easing="ease-in-sine" data-aos-duration="1000">DEVELOPING<br> STAGE</div>

						<div class="desc" data-aos="fade-left" data-aos-easing="ease-in-sine" data-aos-duration="1000" data-aos-delay="1000">
							<p><b>Retrotope is in an advanced clinical stage</b> with anticipated NDA filing in 2022. The company is poised in small and large orphan markets for immediate commercialization and there is a platform of LPO antagonist drugs being readied for larger indications.</p>

							<p><b>Retrotope has begun clinical trials</b> across 4 indications and preliminary results are overwhelmingly positive with profound safety. In early 2021, clinical trials are planned to commence with our 2nd compound RT011 for dry AMD (age-related macular degeneration) a major unmet need retinal disease indication with a TAM of more than 20M patient in US and EU.</p>
						</div>
					</div>

					<div class="bg lozad" data-background-image="images/bg_mission.jpg"></div>

					<div class="parallax scene fill" id="parallax2">
						<img data-src="images/mission_parallax_img.png" alt="" class="img lozad layer layer1 expand-width" data-depth="0.3">
					</div>
				</section>


				<section class="advisory_board block tabs_container">
					<div class="cont">
						<div class="block_head center">
							<div class="title"><span class="gradient">Advisory Board</span></div>
						</div>

						<div class="tabs level1_tabs">
							<button data-content="#advisory_tab1" data-level="level1" class="active">Scientific</button>
							<button data-content="#advisory_tab2" data-level="level1">Clinical & Regulatory</button>
							<button data-content="#advisory_tab3" data-level="level1">Business</button>
						</div>


						<div class="tab_content level1 active tabs_container row" id="advisory_tab1">
							<div class="col_left">
								<div class="title"><b>Scientific</b> Advisory Board</div>

								<div class="tabs level2_tabs">
									<button data-content="#advisory_level2_tab1" data-level="level2" class="active">
										<div class="arr"></div>
										<div>J. Thomas (Tom) Brenna, Ph.D.</div>
									</button>

									<button data-content="#advisory_level2_tab2" data-level="level2">
										<div class="arr"></div>
										<div>Anatoly L. Buchachenko</div>
									</button>

									<button data-content="#advisory_level2_tab3" data-level="level2">
										<div class="arr"></div>
										<div>Charles R. Cantor, Ph.D.</div>
									</button>

									<button data-content="#advisory_level2_tab4" data-level="level2">
										<div class="arr"></div>
										<div>Amato Giaccia, Ph.D.</div>
									</button>

									<button data-content="#advisory_level2_tab5" data-level="level2">
										<div class="arr"></div>
										<div>Aubrey de Grey, Ph.D.</div>
									</button>

									<button data-content="#advisory_level2_tab6" data-level="level2">
										<div class="arr"></div>
										<div>Dr. Richard H. Haas, MB, BChir, MRCP</div>
									</button>

									<button data-content="#advisory_level2_tab7" data-level="level2">
										<div class="arr"></div>
										<div>Michael P. Murphy, Ph.D.</div>
									</button>

									<button data-content="#advisory_level2_tab8" data-level="level2">
										<div class="arr"></div>
										<div>David T. Shima, Ph.D.</div>
									</button>

									<button data-content="#advisory_level2_tab9" data-level="level2">
										<div class="arr"></div>
										<div>Jan Vijg, Ph.D.</div>
									</button>
								</div>
							</div>


							<div class="tab_content level2 active" id="advisory_level2_tab1">
								<div class="person_info">
									<div class="info">
										<div class="photo">
											<img data-src="images/tmp/person_info_photo.png" alt="" class="lozad">
										</div>

										<div class="name">Dr. Richard H. Haas,<br> MB, BChir, MRCP</div>
									</div>

									<div class="text_block">
										<p>is director of the University of California San Diego Mitochondrial Disease Laboratory and Co-Director of the UCSD Mitochondrial and Metabolic Disease Center. He is the founding President of the Mitochondrial Medicine Society. Trained as a Pediatric Neurologist with a research interest in mitochondrial and metabolic diseases Dr. Haas is an active clinician involved with the care of patients of all ages with mitochondrial disease as well as clinical treatment trials in this population.</p>

										<p>His laboratory has focused on the diagnosis and treatment of mitochondrial disease with the development and application of miniaturized techniques for diagnosis and the study of potential treatments. Work with Parkinson disease mitochondria lead to...</p>
									</div>

									<a href="/" class="details">Learn more</a>
								</div>
							</div>


							<div class="tab_content level2" id="advisory_level2_tab2">
								<div class="person_info">
									<div class="info">
										<div class="photo">
											<img data-src="images/tmp/person_info_photo.png" alt="" class="lozad">
										</div>

										<div class="name">Dr. Richard H. Haas,<br> MB, BChir, MRCP</div>
									</div>

									<div class="text_block">
										<p>is director of the University of California San Diego Mitochondrial Disease Laboratory and Co-Director of the UCSD Mitochondrial and Metabolic Disease Center. He is the founding President of the Mitochondrial Medicine Society. Trained as a Pediatric Neurologist with a research interest in mitochondrial and metabolic diseases Dr. Haas is an active clinician involved with the care of patients of all ages with mitochondrial disease as well as clinical treatment trials in this population.</p>

										<p>His laboratory has focused on the diagnosis and treatment of mitochondrial disease with the development and application of miniaturized techniques for diagnosis and the study of potential treatments. Work with Parkinson disease mitochondria lead to...</p>
									</div>

									<a href="/" class="details">Learn more</a>
								</div>
							</div>


							<div class="tab_content level2" id="advisory_level2_tab3">
								<div class="person_info">
									<div class="info">
										<div class="photo">
											<img data-src="images/tmp/person_info_photo.png" alt="" class="lozad">
										</div>

										<div class="name">Dr. Richard H. Haas,<br> MB, BChir, MRCP</div>
									</div>

									<div class="text_block">
										<p>is director of the University of California San Diego Mitochondrial Disease Laboratory and Co-Director of the UCSD Mitochondrial and Metabolic Disease Center. He is the founding President of the Mitochondrial Medicine Society. Trained as a Pediatric Neurologist with a research interest in mitochondrial and metabolic diseases Dr. Haas is an active clinician involved with the care of patients of all ages with mitochondrial disease as well as clinical treatment trials in this population.</p>

										<p>His laboratory has focused on the diagnosis and treatment of mitochondrial disease with the development and application of miniaturized techniques for diagnosis and the study of potential treatments. Work with Parkinson disease mitochondria lead to...</p>
									</div>

									<a href="/" class="details">Learn more</a>
								</div>
							</div>


							<div class="tab_content level2" id="advisory_level2_tab4">
								<div class="person_info">
									<div class="info">
										<div class="photo">
											<img data-src="images/tmp/person_info_photo.png" alt="" class="lozad">
										</div>

										<div class="name">Dr. Richard H. Haas,<br> MB, BChir, MRCP</div>
									</div>

									<div class="text_block">
										<p>is director of the University of California San Diego Mitochondrial Disease Laboratory and Co-Director of the UCSD Mitochondrial and Metabolic Disease Center. He is the founding President of the Mitochondrial Medicine Society. Trained as a Pediatric Neurologist with a research interest in mitochondrial and metabolic diseases Dr. Haas is an active clinician involved with the care of patients of all ages with mitochondrial disease as well as clinical treatment trials in this population.</p>

										<p>His laboratory has focused on the diagnosis and treatment of mitochondrial disease with the development and application of miniaturized techniques for diagnosis and the study of potential treatments. Work with Parkinson disease mitochondria lead to...</p>
									</div>

									<a href="/" class="details">Learn more</a>
								</div>
							</div>


							<div class="tab_content level2" id="advisory_level2_tab5">
								<div class="person_info">
									<div class="info">
										<div class="photo">
											<img data-src="images/tmp/person_info_photo.png" alt="" class="lozad">
										</div>

										<div class="name">Dr. Richard H. Haas,<br> MB, BChir, MRCP</div>
									</div>

									<div class="text_block">
										<p>is director of the University of California San Diego Mitochondrial Disease Laboratory and Co-Director of the UCSD Mitochondrial and Metabolic Disease Center. He is the founding President of the Mitochondrial Medicine Society. Trained as a Pediatric Neurologist with a research interest in mitochondrial and metabolic diseases Dr. Haas is an active clinician involved with the care of patients of all ages with mitochondrial disease as well as clinical treatment trials in this population.</p>

										<p>His laboratory has focused on the diagnosis and treatment of mitochondrial disease with the development and application of miniaturized techniques for diagnosis and the study of potential treatments. Work with Parkinson disease mitochondria lead to...</p>
									</div>

									<a href="/" class="details">Learn more</a>
								</div>
							</div>


							<div class="tab_content level2" id="advisory_level2_tab6">
								<div class="person_info">
									<div class="info">
										<div class="photo">
											<img data-src="images/tmp/person_info_photo.png" alt="" class="lozad">
										</div>

										<div class="name">Dr. Richard H. Haas,<br> MB, BChir, MRCP</div>
									</div>

									<div class="text_block">
										<p>is director of the University of California San Diego Mitochondrial Disease Laboratory and Co-Director of the UCSD Mitochondrial and Metabolic Disease Center. He is the founding President of the Mitochondrial Medicine Society. Trained as a Pediatric Neurologist with a research interest in mitochondrial and metabolic diseases Dr. Haas is an active clinician involved with the care of patients of all ages with mitochondrial disease as well as clinical treatment trials in this population.</p>

										<p>His laboratory has focused on the diagnosis and treatment of mitochondrial disease with the development and application of miniaturized techniques for diagnosis and the study of potential treatments. Work with Parkinson disease mitochondria lead to...</p>
									</div>

									<a href="/" class="details">Learn more</a>
								</div>
							</div>


							<div class="tab_content level2" id="advisory_level2_tab7">
								<div class="person_info">
									<div class="info">
										<div class="photo">
											<img data-src="images/tmp/person_info_photo.png" alt="" class="lozad">
										</div>

										<div class="name">Dr. Richard H. Haas,<br> MB, BChir, MRCP</div>
									</div>

									<div class="text_block">
										<p>is director of the University of California San Diego Mitochondrial Disease Laboratory and Co-Director of the UCSD Mitochondrial and Metabolic Disease Center. He is the founding President of the Mitochondrial Medicine Society. Trained as a Pediatric Neurologist with a research interest in mitochondrial and metabolic diseases Dr. Haas is an active clinician involved with the care of patients of all ages with mitochondrial disease as well as clinical treatment trials in this population.</p>

										<p>His laboratory has focused on the diagnosis and treatment of mitochondrial disease with the development and application of miniaturized techniques for diagnosis and the study of potential treatments. Work with Parkinson disease mitochondria lead to...</p>
									</div>

									<a href="/" class="details">Learn more</a>
								</div>
							</div>


							<div class="tab_content level2" id="advisory_level2_tab8">
								<div class="person_info">
									<div class="info">
										<div class="photo">
											<img data-src="images/tmp/person_info_photo.png" alt="" class="lozad">
										</div>

										<div class="name">Dr. Richard H. Haas,<br> MB, BChir, MRCP</div>
									</div>

									<div class="text_block">
										<p>is director of the University of California San Diego Mitochondrial Disease Laboratory and Co-Director of the UCSD Mitochondrial and Metabolic Disease Center. He is the founding President of the Mitochondrial Medicine Society. Trained as a Pediatric Neurologist with a research interest in mitochondrial and metabolic diseases Dr. Haas is an active clinician involved with the care of patients of all ages with mitochondrial disease as well as clinical treatment trials in this population.</p>

										<p>His laboratory has focused on the diagnosis and treatment of mitochondrial disease with the development and application of miniaturized techniques for diagnosis and the study of potential treatments. Work with Parkinson disease mitochondria lead to...</p>
									</div>

									<a href="/" class="details">Learn more</a>
								</div>
							</div>


							<div class="tab_content level2" id="advisory_level2_tab9">
								<div class="person_info">
									<div class="info">
										<div class="photo">
											<img data-src="images/tmp/person_info_photo.png" alt="" class="lozad">
										</div>

										<div class="name">Dr. Richard H. Haas,<br> MB, BChir, MRCP</div>
									</div>

									<div class="text_block">
										<p>is director of the University of California San Diego Mitochondrial Disease Laboratory and Co-Director of the UCSD Mitochondrial and Metabolic Disease Center. He is the founding President of the Mitochondrial Medicine Society. Trained as a Pediatric Neurologist with a research interest in mitochondrial and metabolic diseases Dr. Haas is an active clinician involved with the care of patients of all ages with mitochondrial disease as well as clinical treatment trials in this population.</p>

										<p>His laboratory has focused on the diagnosis and treatment of mitochondrial disease with the development and application of miniaturized techniques for diagnosis and the study of potential treatments. Work with Parkinson disease mitochondria lead to...</p>
									</div>

									<a href="/" class="details">Learn more</a>
								</div>
							</div>
						</div>


						<div class="tab_content level1" id="advisory_tab2 row">

						</div>


						<div class="tab_content level1" id="advisory_tab3 row">

						</div>
					</div>
				</section>


				<section class="collaborations">
					<div class="cont row">
						<div class="icon">
							<img data-src="images/ic_collaborations.png" alt="" class="lozad">
						</div>

						<div class="info">
							<a href="/" class="details">See</a>

							<div class="title">OUR COLLABORATIONS WORLDWIDE NETWORK</div>

							<img data-src="images/tmp/collaborations_img.png" alt="" class="lozad">
						</div>
					</div>
				</section>


				<section class="news">
					<div class="cont">
						<div class="block_head center">
							<div class="title"  data-aos="fade-down" data-aos-easing="ease-in-sine" data-aos-duration="1000">LATEST PUBLICATIONS</div>
						</div>

						<div class="row">
							<div class="list">
								<a href="/" class="item hover" data-index="1" data-aos="fade-right" data-aos-easing="ease-in-sine" data-aos-duration="500" data-aos-delay="500">
									<div class="arr"></div>

									<div class="name"><b>September 2020</b> - Could including deuterated fatty acids in our diets one day help us to lead healthier and longer lives with reduced risk of neurodegenerative diseases, asks Vadim Demidov</div>
								</a>

								<a href="/" class="item" data-index="2" data-aos="fade-left" data-aos-easing="ease-in-sine" data-aos-duration="500" data-aos-delay="1000">
									<div class="arr"></div>

									<div class="name"><b>September 2020</b> - Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001 (bis-Allylic 11,11-D2-Linoleic Acid Ethyl Ester) during Long Term Dosing in Patients</div>
								</a>

								<a href="/" class="item" data-index="3" data-aos="fade-right" data-aos-easing="ease-in-sine" data-aos-duration="500" data-aos-delay="1500">
									<div class="arr"></div>

									<div class="name"><b>August 14, 2020</b> – Retrotope Announces CEO and Chairman Transitions</div>
								</a>

								<a href="/" class="item" data-index="4" data-aos="fade-left" data-aos-easing="ease-in-sine" data-aos-duration="500" data-aos-delay="2000">
									<div class="arr"></div>

									<div class="name"><b>April 25, 2020</b> - US FDA Allows Trial to Proceed for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)</div>
								</a>

								<a href="/" class="item" data-index="5" data-aos="fade-right" data-aos-easing="ease-in-sine" data-aos-duration="500" data-aos-delay="2500">
									<div class="arr"></div>

									<div class="name"><b>September 2020</b> - Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001 (bis-Allylic 11,11-D2-Linoleic Acid Ethyl Ester) during Long Term</div>
								</a>

								<a href="/" class="item" data-index="6" data-aos="fade-left" data-aos-easing="ease-in-sine" data-aos-duration="500" data-aos-delay="3000">
									<div class="arr"></div>

									<div class="name"><b>September 2020</b> - Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001 (bis-Allylic 11,11-D2-Linoleic Acid Ethyl Ester) during Long Term Dosing in Patients</div>
								</a>
							</div>


							<div class="news_details"  data-aos="fade-left" data-aos-easing="ease-in-sine" data-aos-duration="1000" data-aos-delay="3000">
								<div class="item" data-index="1" style="display: block;">
									<div class="thumb">
										<img data-src="images/tmp/news_details_thumb.jpg" alt="" class="lozad">
									</div>

									<div class="info">
										<div class="desc">In the mid-2000s, Oxford University scientist Mikhail Shchepinov had the novel idea to use non-radioactive heavy isotopes to slow down ageing. His idea revolved around the slowing of free radical damage in the body caused by reactive oxygen species (ROS), one of the principal causes of ageing and ageassociated diseases.</div>

										<a href="/" class="details">Read more</a>
									</div>
								</div>

								<div class="item" data-index="2">
									<div class="thumb">
										<img data-src="images/tmp/news_details_thumb.jpg" alt="" class="lozad">
									</div>

									<div class="info">
										<div class="desc">In the mid-2000s, Oxford University scientist Mikhail Shchepinov had the novel idea to use non-radioactive heavy isotopes to slow down ageing. His idea revolved around the slowing of free radical damage in the body caused by reactive oxygen species (ROS), one of the principal causes of ageing and ageassociated diseases.</div>

										<a href="/" class="details">Read more</a>
									</div>
								</div>

								<div class="item" data-index="3">
									<div class="thumb">
										<img data-src="images/tmp/news_details_thumb.jpg" alt="" class="lozad">
									</div>

									<div class="info">
										<div class="desc">In the mid-2000s, Oxford University scientist Mikhail Shchepinov had the novel idea to use non-radioactive heavy isotopes to slow down ageing. His idea revolved around the slowing of free radical damage in the body caused by reactive oxygen species (ROS), one of the principal causes of ageing and ageassociated diseases.</div>

										<a href="/" class="details">Read more</a>
									</div>
								</div>

								<div class="item" data-index="4">
									<div class="thumb">
										<img data-src="images/tmp/news_details_thumb.jpg" alt="" class="lozad">
									</div>

									<div class="info">
										<div class="desc">In the mid-2000s, Oxford University scientist Mikhail Shchepinov had the novel idea to use non-radioactive heavy isotopes to slow down ageing. His idea revolved around the slowing of free radical damage in the body caused by reactive oxygen species (ROS), one of the principal causes of ageing and ageassociated diseases.</div>

										<a href="/" class="details">Read more</a>
									</div>
								</div>

								<div class="item" data-index="5">
									<div class="thumb">
										<img data-src="images/tmp/news_details_thumb.jpg" alt="" class="lozad">
									</div>

									<div class="info">
										<div class="desc">In the mid-2000s, Oxford University scientist Mikhail Shchepinov had the novel idea to use non-radioactive heavy isotopes to slow down ageing. His idea revolved around the slowing of free radical damage in the body caused by reactive oxygen species (ROS), one of the principal causes of ageing and ageassociated diseases.</div>

										<a href="/" class="details">Read more</a>
									</div>
								</div>

								<div class="item" data-index="6">
									<div class="thumb">
										<img data-src="images/tmp/news_details_thumb.jpg" alt="" class="lozad">
									</div>

									<div class="info">
										<div class="desc">In the mid-2000s, Oxford University scientist Mikhail Shchepinov had the novel idea to use non-radioactive heavy isotopes to slow down ageing. His idea revolved around the slowing of free radical damage in the body caused by reactive oxygen species (ROS), one of the principal causes of ageing and ageassociated diseases.</div>

										<a href="/" class="details">Read more</a>
									</div>
								</div>
							</div>
						</div>
					</div>
				</section>
			</div>


			<footer>
				<div class="info">
					<div class="cont row">
						<div class="links">
							<div class="title">Patients</div>

							<div class="items">
								<div><a href="/">Advocacy Group</a></div>
							</div>
						</div>

						<div class="links">
							<div class="title">
								<a href="/">Healthcare<br> providers</a>
							</div>
						</div>

						<div class="links">
							<div class="title">Science</div>

							<div class="items">
								<div><a href="/">Technology</a></div>
								<div><a href="/">Indications</a></div>
								<div><a href="/">Clinical Trials</a></div>
								<div><a href="/">Collaborations</a></div>
								<div><a href="/">Scientific Advisory Board</a></div>
							</div>
						</div>

						<div class="links">
							<div class="title">Pipeline</div>

							<div class="items">
								<div><a href="/">RT011</a></div>
								<div><a href="/">RT001</a></div>
							</div>
						</div>

						<div class="links">
							<div class="title">Careers</div>

							<div class="items">
								<div><a href="/">RT011</a></div>
								<div><a href="/">RT001</a></div>
							</div>
						</div>

						<div class="links">
							<div class="title">About Retrotope</div>

							<div class="items">
								<div><a href="/">Corporate Governance</a></div>
								<div><a href="/">Financial updates</a></div>
							</div>
						</div>
					</div>
				</div>


				<div class="bottom">
					<div class="cont row">
						<div class="address">RETROTOPE, 4300 EL CAMINO REAL, SUITE 201, LOS ALTOS, CA 94022</div>

						<div class="socials">
							<a href="/" target="_blank" rel="noopener nofollow" class="facebook">
								<svg class="icon"><use xlink:href="images/sprite.svg#ic_facebook"></use></svg>
							</a>

							<a href="/" target="_blank" rel="noopener nofollow" class="linkedin">
								<svg class="icon"><use xlink:href="images/sprite.svg#ic_linkedin"></use></svg>
							</a>

							<a href="/" target="_blank" rel="noopener nofollow" class="twitter">
								<svg class="icon"><use xlink:href="images/sprite.svg#ic_twitter"></use></svg>
							</a>

							<a href="/" target="_blank" rel="noopener nofollow" class="wikipedia">
								<svg class="icon"><use xlink:href="images/sprite.svg#ic_wikipedia"></use></svg>
							</a>
						</div>

						<div class="copyright">Copyright &copy; 2015-2018 Retrotope Inc. </div>
					</div>
				</div>
			</footer>


			<div class="buttonUp">
				<button>
					<svg class="icon"><use xlink:href="images/sprite.svg#ic_buttonUp"></use></svg>
				</button>
			</div>

			<div class="overlay"></div>
		</div>


		<div class="supports_error">
			Ваш браузер устарел рекомендуем обновить его до последней версии<br> или использовать другой более современный.
		</div>


		<!-- Подключение javascript файлов -->
		<script src="js/jquery-3.5.0.min.js"></script>
		<script src="js/lozad.min.js"></script>
		<script src="js/owl.carousel.min.js"></script>
		<script src="js/parallax.js"></script>
		<script src="js/fancybox.min.js"></script>
		<script src="js/functions.js"></script>
		<script src="https://unpkg.com/aos@2.3.1/dist/aos.js"></script>
		<script src="js/scripts.js"></script>
	</body>
</html>